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Early identification of the pathogenic organisms and 
proper antimicrobial treatment are essential to treating 
patients with pneumonia. Therefore, respiratory physi-
cians have long tried to find a sensitive, specific, and safe 
method to obtain causative lower respiratory pathogens 
from such patients.
Expectorated sputum culture has been the most fre-
quently used method in the clinic. However, due to upper 
airway contamination, it has a low sensitivity and speci-
ficity. In order to exclude contamination by upper airway 
microorganisms, the transtracheal aspiration method has 
been used to bypass the upper airway, but this also has 
limitations due to various complicating factors.
Because bronchoscopic examination is used commonly 
in the clinic, its role in identifying respiratory pathogens 
has been investigated. Use of a protected specimen brush 
and quantitative cultures of bronchoalveolar lavage (BAL) 
fluid are considered the most reliable methods to evaluate 
patients with pneumonia.
In the 1980s, two studies reported on quantitative cul-
tures of BAL fluid. Kahn and Jones [1] prospectively evalu-
ated both 75 patients and 18 controls without evidence of 
respiratory infection for the presence of lower respiratory 
tract bacterial infections. Because they detected greater 
than 10
5 colony forming units (cfu) per milliliter, and less 
than 1% squamous epithelial cells in BAL fluid, the authors 
of that study concluded that BAL was useful for diagnosis 
of bacterial respiratory infections. Thorpe et al. [2] also 
reported that the BAL technique was useful for identify-
ing causative pathogens in patients with acute bacterial 
pneumonia, as well as in immunocompromised patients 
presenting with pulmonary infiltrates with a positive BAL 
culture greater than 10
5 cfu/mL.
Subsequently, many studies aimed to identify the 
causative pathogens in patients with not only commu-
nity-acquired pneumonia, but also with nosocomial, 
ventilator-associated pneumonia and pneumonia in im-
munocompromised patients.
Bronchoscopic examination seems more likely to find 
the etiologic organisms of pneumonia and less likely to 
have upper airway contamination compared to expecto-
rated sputum analysis. However, it is less likely to detect 
etiologic organisms, especially when patients have re-
ceived antibiotics before the bronchoscopic examination.
Kim et al. [3] found that the quantitative bacterial cul-
ture yield from BAL fluid was as low as 2.94% in patients 
with pneumonia who were concurrently receiving anti-
microbials. This BAL yield was notably lower than that of 
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previous studies, which reported 30-80% culture rates. 
Kim et al. [3] suggested that the lower yield in their study 
may have been caused by the concurrent use of antimi-
crobials. Considering that the use of antimicrobials before 
specimen culture decreased the yields of blood and spu-
tum cultures, the long duration of antimicrobial treatment 
in their study (45% of patients received antimicrobials 
for more than one week before BAL) could explain their 
significantly lower yield. However, there may also be other 
reasons for the discrepant results [4].
First, the definition of a positive BAL yield is not uni-
form. The threshold for a positive bacterial culture yield 
from BAL fluid has been defined as 10
3-10
5 cfu/mL; this 
varies among studies. In earlier studies, a BAL culture 
yield greater than or equal to 10
5 cfu/mL was considered 
positive, but more recent studies have indicated that 10
4 
cfu/mL is more sensitive and specific. 
Second, differences in methodology exist. The amount 
of normal saline instilled during BAL is variable. Tradi-
tionally, infusion of more than 120 mL saline was recom-
mended for adequate sampling of a pulmonary segment. 
Moon et al. [5] used mini-BAL, which retrieved only 25 
mL BAL fluid, to isolate the causative pathogens of ventila-
tor-associated pneumonia. They reported that the amount 
of normal saline required to retrieve 25 mL of BAL fluid 
was 93 ± 32 mL, which is markedly less than the tradi-
tional infusion volume of 120 mL. 
Third, the patient populations used in these studies 
were large, and diverse, including those with bone marrow 
transplantation or solid organ transplantation, as well as 
non-immunocompromised patients with or without vari-
ous medical illnesses. 
Fourth, the concurrent use and/or duration of use of an-
timicrobials varied among the studies. It is known that the 
yields of blood and sputum cultures significantly decrease 
with the use of precultural antimicrobials. Previous stud-
ies have reported that the yield of bacterial pathogens is 
influenced by the concurrent use and/or duration of use of 
antimicrobials [6]. Kottmann et al. [7] reported that if BAL 
was performed within three days of starting treatment-
dose antibiotics, the overall yield was 63.4%, but was 
reduced to 57.6% and 34.4% when performed within 3-14 
days or after 14 days, respectively. Therefore, they suggest-
ed that the optimal time for performance of BAL is within 
three days of the initiation of broad-spectrum antibiotics.
In conclusion, bronchoscopy in conjunction with quanti-
tative BAL fluid culture is a useful strategy for identifying 
causative pathogens in diverse populations of patients with 
pneumonia. The utility of quantitative BAL fluid cultures 
may be limited in patients receiving antibiotic therapy. 
Therefore, physicians should use caution when deciding 
whether BAL is necessary, weighing the risks and benefits, 
and, if so, when is the best time to perform the procedure 
if the patients are receiving antibiotic therapy. Further 
studies are needed to standardize the BAL technique and 
the optimal time to perform the procedure in patients with 
pneumonia who are also receiving antimicrobial treat-
ment.
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